Cybin Inc. (CYBN)
USD 9.46
(-0.11%)
USD 9.46
(-0.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.89 Million CAD | 127.46% |
| 2022 | 1.27 Million CAD | 699.53% |
| 2021 | -212 Thousand CAD | -1456852906803300.0% |
| 2020 | - CAD | -100.0% |
| 2019 | 1.00 CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - CAD | -100.0% |
| 2023 Q3 | - CAD | -100.0% |
| 2023 FY | 2.89 Million CAD | 127.46% |
| 2023 Q1 | 1.26 Million CAD | -27.29% |
| 2023 Q4 | 2.89 Million CAD | 0.0% |
| 2023 Q2 | 3.06 Million CAD | 143.25% |
| 2022 Q2 | 3.16 Million CAD | 151.51% |
| 2022 FY | 1.27 Million CAD | 699.53% |
| 2022 Q4 | 1.73 Million CAD | -40.06% |
| 2022 Q3 | 2.89 Million CAD | -8.77% |
| 2022 Q1 | 1.26 Million CAD | -0.87% |
| 2021 Q1 | - CAD | -100.0% |
| 2021 FY | -212 Thousand CAD | -1456852906803300.0% |
| 2021 Q4 | 1.27 Million CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | -100.0% |
| 2020 Q3 | 274.23 Thousand CAD | -40.36% |
| 2020 Q2 | 459.85 Thousand CAD | -17.58% |
| 2020 Q1 | 557.96 Thousand CAD | 0.0% |
| 2020 Q4 | - CAD | -100.0% |
| 2019 FY | 1.00 CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -1.18 Million USD | 344.173% |
| Ampio Pharmaceuticals, Inc. | 1.00 USD | -289099900.0% |
| Armata Pharmaceuticals, Inc. | - USD | -Infinity% |
| Actinium Pharmaceuticals, Inc. | - USD | -Infinity% |
| Azitra, Inc. | -215.21 Thousand USD | 1443.283% |
| Can-Fite BioPharma Ltd. | - USD | -Infinity% |
| Chromocell Therapeutics Corporation | - USD | -Infinity% |
| Calidi Biotherapeutics, Inc. | - USD | -Infinity% |
| CEL-SCI Corporation | 2.24 Million USD | -28.599% |
| iBio, Inc. | - USD | -Infinity% |
| Lineage Cell Therapeutics, Inc. | - USD | -Infinity% |
| MAIA Biotechnology, Inc. | - USD | -Infinity% |
| Matinas BioPharma Holdings, Inc. | - USD | -Infinity% |
| Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | -576.504% |
| NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | -0.487% |
| NanoViricides, Inc. | - USD | -Infinity% |
| Oragenics, Inc. | - USD | -Infinity% |
| BiomX Inc. | - USD | -Infinity% |
| BiomX Inc. | - USD | -Infinity% |
| Protalix BioTherapeutics, Inc. | 19.04 Million USD | 84.82% |
| Palatin Technologies, Inc. | - USD | -Infinity% |
| Scorpius Holdings, Inc. | 909.15 Thousand USD | -217.987% |